Literature DB >> 33961858

m6A demethylase ALKBH5 suppresses proliferation and migration of enteric neural crest cells by regulating TAGLN in Hirschsprung's disease.

Binyu Wang1, Xiang Fang1, Xinhe Sun2, Chunxia Du1, Lingling Zhou1, Xiurui Lv3, Yuhan Li1, Hongxing Li2, Weibing Tang4.   

Abstract

OBJECTIVES: This study aims to investigate the role of demethylase ALKBH5 mediated demethylation of TAGLN mRNA in the occurrence of Hirschsprung's disease (HSCR), and to clarify how ALKBH5 reduces the m6A level of TAGLN mRNA and inhibits its degradation, thereby inhibiting the proliferation and migration of neural crest cells, and potentially contributing to the occurrence of HSCR.
MATERIAL AND METHODS: Quantitative real-time PCR (qRT-PCR) and Western-Blot (WB) were conducted to test the expression level of ALKBH5 and TAGLN genes. Cell function assays were adopted to detect cell phenotypes. The qRT-PCR and methylated RNA immunoprecipitation (MeRIP-qPCR) were used to test the regulation of TAGLN by ALKBH5.
RESULTS: 1. Compared with control intestinal tissue, the expression level of TAGLN and ALKBH5 in the aganglionic intestinal tissue of HSCR is increased. 2. The MeRIP-PCR and dualluciferase report confirmed that ALKBH5 could bind to m6A sites of TAGLN mRNA and reduce the m6A level of TAGLN mRNA. 3. In vitro cell experiments confirmed that overexpression of ALKBH5 can inhibit the degradation of TAGLN mRNA, increase the expression of TAGLN, thereby inhibiting cell proliferation and migration. 4. A zebrafish model of ALKBH5 overexpression was constructed. Studies have shown that ALKBH5 could inhibit the proliferation and migration of zebrafish enteric neurons.
CONCLUSIONS: ALKBH5 could demethylate TAGLN mRNA and up-regulate TAGLN expression, leading to the inhibition of proliferation and migration of enteric neural crest cells and contributing to the occurrence of HSCR.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ALKBH5; Cell migration; Cell proliferation; Hirschsprung's disease; N(6)-methyladenosine; TAGLN

Year:  2021        PMID: 33961858     DOI: 10.1016/j.lfs.2021.119577

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

1.  m6A demethylase ALKBH5 suppression contributes to esophageal squamous cell carcinoma progression.

Authors:  Dong Xiao; Ting-Xiao Fang; Ye Lei; Sheng-Jun Xiao; Jia-Wei Xia; Tao-Yan Lin; Yong-Long Li; Jian-Xue Zhai; Xiao-Yan Li; Shi-Hao Huang; Jun-Shuang Jia; Yu-Guang Tian; Xiao-Lin Lin; Kai-Can Cai; Yan Sun
Journal:  Aging (Albany NY)       Date:  2021-09-07       Impact factor: 5.682

Review 2.  The N6-Methyladenosine Modification and Its Role in mRNA Metabolism and Gastrointestinal Tract Disease.

Authors:  Teng Cai; Lawrence Lawer Atteh; Xianzhuo Zhang; Chongfei Huang; Mingzhen Bai; Haidong Ma; Chao Zhang; Wenkang Fu; Long Gao; Yanyan Lin; Wenbo Meng
Journal:  Front Surg       Date:  2022-01-28

Review 3.  RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential.

Authors:  Jianwei Qu; Haimeng Yan; Yifan Hou; Wen Cao; Yang Liu; Enfan Zhang; Jingsong He; Zhen Cai
Journal:  J Hematol Oncol       Date:  2022-01-21       Impact factor: 17.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.